LifeStance Health (LFST) Net Cash Flow (2020 - 2026)

LifeStance Health (LFST) has 7 years of Net Cash Flow data on file, last reported at -$53.8 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$53.8 million, down 166.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.5 million (down 28.77% YoY), and the FY2025 annual result was $94.1 million, up 24.19% from the prior year.
• Net Cash Flow fell to -$53.8 million in Q1 2026 per LFST's latest filing, from $44.7 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $54.6 million in Q2 2025 and troughed at -$53.8 million in Q1 2026.
• A 5-year average of $2.8 million and a median of $11.3 million in 2023 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow tumbled 482.68% in 2023, then jumped 231.69% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $18.3 million in 2022, then jumped by 98.08% to $36.2 million in 2023, then surged by 43.45% to $52.0 million in 2024, then declined by 13.89% to $44.7 million in 2025, then slumped by 220.35% to -$53.8 million in 2026.
• Business Quant data shows LFST's Net Cash Flow at -$53.8 million in Q1 2026, $44.7 million in Q4 2025, and $15.0 million in Q3 2025.